<scp>MRONJ</scp> Risk Related to Dental Implants in Osteoporosis Treated With Denosumab: A Systematic Review
The current literature shows high heterogeneity, small sample sizes, and a lack of standardization, making it difficult to draw definitive conclusions. However, despite MRONJ being relatively rare, important factors were identified that could influence outcomes, such as transitioning from bisphosphonates to denosumab therapy, timing of implant placement, and the presence of peri-implantitis.
Authors
- Matteo Biasotto (ORCID: https://orcid.org/0000-0001-6024-6115)
- Katia Rupel (ORCID: https://orcid.org/0000-0002-6150-9439)
- Roberto Di Lenarda
- Rebheca Maria Pereira Santos
Institutions
- University of Trieste (IT)
- ASL Roma (IT)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
Publication Details
- Journal
- Oral Diseases
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1111/odi.70181
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00